HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.

AbstractBACKGROUND:
The treatment of stage I Merkel cell carcinoma (MCC) usually includes wide local excision (WLE) combined with irradiation of the tumor bed (ITB). No randomized study has ever been conducted in MCC. The purpose of this study was to assess the efficacy and safety of prophylactic adjuvant radiotherapy on the regional nodes.
PATIENTS AND METHODS:
In this randomized open controlled study, patients for a stage I MCC treated by WLE and ITB were randomly assigned to regional adjuvant radiotherapy versus observation. Overall survival (OS) and probability of regional recurrence (PRR) were primary end points. Progression-free survival (PFS) and tolerance of irradiation were secondary end points.
RESULTS:
Eighty-three patients were included before premature interruption of the trial, due to a drop in the recruitment mainly due to the introduction of the sentinel node dissection in the management of MCC. No significant improvement in OS (P = 0.989) or PFS (P = 0.4) could be demonstrated after regional irradiation, which, however, significantly reduced the PRR (P = 0.007) with 16.7% regional recurrence rate in the observation arm versus 0% in the treatment arm. The treatment was well tolerated.
CONCLUSION:
The adjuvant regional irradiation significantly decreased the PRR in MCC, but benefit in survival could not be demonstrated.
AuthorsT Jouary, C Leyral, B Dreno, A Doussau, B Sassolas, M Beylot-Barry, C Renaud-Vilmer, B Guillot, P Bernard, C Lok, C Bedane, F Cambazard, L Misery, E Estève, S Dalac, L Machet, F Grange, P Young, F Granel-Brocard, F Truchetet, B Vergier, M M Delaunay, J J Grob, Groupe de Cancérologie Cutanée of the Société Française de Dermatologie
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 23 Issue 4 Pg. 1074-80 (Apr 2012) ISSN: 1569-8041 [Electronic] England
PMID21750118 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Merkel Cell (mortality, pathology, radiotherapy, surgery)
  • Disease-Free Survival
  • Early Termination of Clinical Trials
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Prospective Studies
  • Radiotherapy, Adjuvant
  • Skin Neoplasms (mortality, pathology, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: